Description
B4GALNT3 Antibody | 26-378 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human, Mouse
Homology: N/A
Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human B4GALNT3.
Research Area: Membrane, Cancer, Signal Transduction
Tested Application: E, WB
Application: B4GALNT3 antibody can be used for detection of B4GALNT3 by ELISA at 1:62500. B4GALNT3 antibody can be used for detection of B4GALNT3 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50, 000 - 100, 000.
Specificiy: N/A
Positive Control 1: Cat. No. 1201 - HeLa Cell Lysate
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: 115 kDa
Validation: N/A
Isoform: N/A
Purification: Antibody is purified by peptide affinity chromatography method.
Clonality: Polyclonal
Clone: N/A
Isotype: N/A
Conjugate: Unconjugated
Physical State: Liquid
Buffer: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Concentration: batch dependent
Storage Condition: For short periods of storage (days) store at 4˚C. For longer periods of storage, store B4GALNT3 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
Alternate Name: B4GALNT3, B4GalNac-T3, FLJ16224, FLJ40362,
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: B4GALNT3 transfers N-acetylgalactosamine (GalNAc) onto glucosyl residues to form N, N-prime-diacetyllactosediamine (LacdiNAc, or LDN) , a unique terminal structure of cell surface N-glycans. It mediates the N, N'-diacetyllactosediamine formation on gastric mucosa.